用于放射性药物和分子成像的人工智能
Jinping Tao1, Ling Liang2, Siqi Hao1,3
1State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing 100142, China.
人工智能 (AI) 正在彻底改变放射性药物开发和精确核医学分子成像. 人工智能增强了药物发现,分子成像分析和临床翻译,加速了个性化治疗.
科学领域:
- 核医学是一种核医学.
- 放射性药物科学 放射性药物科学
- 人工智能的人工智能
背景情况:
- 精确的核医学依赖于放射性药物和分子成像.
- 人工智能 (AI) 在这些领域提供了变革性的潜力.
- 数据中心的人工智能模式正在推动创新.
研究的目的:
- 审查在放射性药物发现和分子成像中最先进的AI应用.
- 调查关键领域的AI技术原则和用例.
- 讨论AI在临床翻译中的挑战和未来方向.
主要方法:
- 专注于深度学习算法,如GNN,GAN和变压器模型.
- 整合多主题数据和3D结构信息.
- 在目标识别,带设计和图像分析中对人工智能的系统研究.
主要成果:
- 人工智能显著改善了放射性药物向 afinity 预测和配体设计.
- 人工智能通过低剂量重建,细分和定量分析增强分子成像 (SPECT/PET).
- 人工智能提高了个性化治疗的诊断效率和准确性.
结论:
- 人工智能是加速放射性药物开发和分子成像的强大工具.
- 解决数据隐私,概括和伦理挑战对于临床翻译至关重要.
- 多学科的整合和技术创新将推动AI在精准医学领域的发展.
更多相关视频
09:08Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method
Published on: December 20, 2024
09:55Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
Published on: October 4, 2024
相关概念视频
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
Magnetic Resonance Imaging
